title: Social phobia and clonazepam.
abstract: Five patients meeting the DSM-III-R criteria for social phobia, without any other psychiatric diagnosis, were treated with clonazepam, a high potency benzodiazepine. All patients improved markedly within four weeks. By the end of the eighth week of treatment, a marked improvement of their symptoms was reported. The adverse effects were minimal at an average dose of 3 mg per day. The authors suggest that clonazepam is a safe and effective medication in the treatment of social phobia. Moreover, clonazepam is easier to use as compared to other drugs which are used (atenolol, phenelzine, alprazolam).
authors.affiliation: Research Centre, Louis-H. Lafontaine Hospital, Montreal, Quebec.
authors.forename: A
authors.initials: A
authors.lastname: Ontiveros
authors.forename: R
authors.initials: R
authors.lastname: Fontaine
mesh_terms: D000328:Adult; D001143:Arousal / Q000187:drug effects; D002998:Clonazepam / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010698:Phobic Disorders / Q000188:drug therapy* / Q000523:psychology
chemical_list: D002998:Clonazepam